Danaher news and events in 2026
Danaher is a life sciences and diagnostics innovator that develops technologies and tools for the biotechnology and clinical sectors. The organization partners with researchers and clinicians to integrate workflows and solve technical problems within a connected ecosystem of specialized firms.
Public (DHR)Biotechnology Research10,000+ employeesdanaher.comLinkedIn
Get Danaher's live signals in Claude or ChatGPT, or by API
What changed at Danaher this week? Use Autobound signals for danaher.com.- Dated updates
- 48
- Last event
- Oct 21, 2026
- Open rolesSnapshot Nov 3, 2026
- 108
- Latest SEC filing
- Oct 20, 2026
Source: Autobound Signal API · 48 signals tracked for Danaher · updated
Overview
Danaher by topic
110-K filing
108open roles
Latest events
Latest Danaher events
Showing 10 of 13 events. The Signal API returns all of them.
Get them with one API call- EarningsDanaher reports growth as Danaher stock trades at EUR 205.60Danaher reported net earnings from continuing operations of USD 1.20 billion for the third quarter of 2026.
- PartnershipDanaher Collaborates with NVIDIA to Advance Autonomous ScienceDanaher Corporation announced a collaboration with NVIDIA to advance autonomous science by integrating NVIDIA accelerated computing and AI technologies into Danaher's scientific instruments and laboratory workflows.
- In developmentDanaher Accelerates Life Sciences Research with New AI-powered Autonomous LabDanaher Corporation announced plans to launch its first AI-powered autonomous lab expected to operate at scale in early 2027.
- LaunchDanaher raises full-year guidance as Danaher stock costs EUR 207.00Danaher announced an autonomous laboratory designed to accelerate research from discovery to breakthrough.
- NewsDanaher schedules third-quarter results: Danaher stock is valued at USD 157.8 billionJulie Sawyer Montgomery, president and chief executive officer
- EarningsDanaher Schedules Third Quarter 2026 Earnings Conference CallDanaher Corporation will hold its quarterly earnings conference call for the third quarter of 2026 on October 21, 2026.
- NewsBRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and StrategyChandra Ramanathan, Vice President and Global Head of Innovation Hubs and Head of External Innovation, Life Sciences Innovation Group (LSIG)
- EarningsDanaher stock holds above $216 as fresh institutional buying follows Q2 beatDanaher Corp. reported earnings per share of $1.94 for the second quarter of 2026, surpassing the consensus estimate of $1.85.
- NewsDanaher Stock: Julie Sawyer Montgomery CEO from October 1Rainer Blair, President and Chief Executive Officer
- PromotionDanaher Stock: Julie Sawyer Montgomery New CEO from OctoberJulie Sawyer Montgomery, President and CEO
Showing 10 of 13 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Danaher with the Signal API
One POST /v1/companies/enrich call with danaher.com returns every signal type for Danaher, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"danaher.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to Danaher
Danaher questions
What is the latest news on Danaher?
What is going on with Danaher?
What else does Autobound track for Danaher?
Is Danaher hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .